FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 110 - National Kidney and Urologic Diseases Advisory Board - Statutory (Congress Created)

GENERAL INFORMATION

Committee Name	National Kidney and Urologic Diseases Advisory Board	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	110
Original Establishment Date	11/20/1985	Committee Status	Administratively Inactive
Actual Termination Date		Committee URL
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	0
Terminated This FY	No	Designated Fed Officer Position Title*	Committee Management Officer
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	9/30/1992	Designated Federal Officer First Name*	Devon
Date Of Renewal Charter	9/30/1994	Designated Federal Officer Middle Name
Projected Termination Date		Designated Federal Officer Last Name*	Drew
Exempt From Renewal*	No	Designated Federal Officer Suffix
Specific Termination Authority		Designated Federal Officer Phone*	(301) 402-9332
Establishment Authority*	Statutory (Congress Created)	Designated Federal Officer Fax*	301-480-2687
Specific Establishment Authority*	42 U.S.C. 285c-4	Designated Federal Officer Email*	devond@niddk.nih.gov
Effective Date Of Authority*	11/20/1985
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Terminate
Legislation to Terminate Required	Yes
Legislation Status	Pending
How does cmte accomplish its purpose?*	NA
How is membership balanced?*	N/A
How frequent & relevant are cmte mtgs?*	N/A
Why advice can't be obtained elsewhere?*	N/A
Why close or partially close meetings?	N/A
Recommendation Remarks	In FY19, this committee was recommended for termination by HHS to OMB under Executive Order 13875. There were no meetings, members, costs, or reports in FY24. This committee does not have a website. Because this committee is administratively inactive and recommended for termination, the positions of committee designated federal official and committee decision maker are held by the same person.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	No	Action Reorganize Priorities*	No
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	No	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	No	Action Other	No
Outcome Increased Customer Satisfaction	No	Action Comment	N/A
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	N/A	Number Of Grants Recommended	0
Cost Savings*	None	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	NA	Grants Review Comment	NA
Number Of Recommendations*	0	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	NA	Access Agency Website	No
% of Recs Fully Implemented*	0.00%	Access Committee Website	No
% of Recs Fully Implemented Comment	NA	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	NA	Access Other	No
Agency Feedback*	Not Applicable	Access Comment	N/A
Agency Feedback Comment*	NA	Narrative Description*	NIH has recommended this committee for termination.

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	3/14/2025 9:26 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Health Safety Medicine Diseases Illnesses

Custom Links

Committee Level Reports